Published in Bioorg Med Chem Lett on January 07, 2011
The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options. Int J Obes (Lond) (2013) 1.04
Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016. Biochim Biophys Acta (2017) 0.78
Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. J Biol Chem (2008) 2.51
Circumdatin A, B, and C: Three New Benzodiazepine Alkaloids Isolated from a Culture of the Fungus Aspergillus ochraceus. J Org Chem (1999) 2.02
High constitutive signaling of the ghrelin receptor--identification of a potent inverse agonist. Mol Endocrinol (2003) 1.97
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss. J Clin Invest (2014) 1.61
Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity. J Clin Endocrinol Metab (2004) 1.50
Structure-activity and protraction relationship of long-acting glucagon-like peptide-1 derivatives: importance of fatty acid length, polarity, and bulkiness. J Med Chem (2007) 1.26
Three distinct epitopes on the extracellular face of the glucagon receptor determine specificity for the glucagon amino terminus. J Biol Chem (2003) 1.23
The WSXWS motif in cytokine receptors is a molecular switch involved in receptor activation: insight from structures of the prolactin receptor. Structure (2012) 1.22
Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: studies in obese and normal-weight subjects. J Clin Endocrinol Metab (2004) 1.17
Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain. Biochemistry (2007) 1.14
Recognition of privileged structures by G-protein coupled receptors. J Med Chem (2004) 1.03
Laboratory animals as surrogate models of human obesity. Acta Pharmacol Sin (2012) 1.01
Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individuals. Diabetologia (2013) 0.99
Chronic administration of the glucagon-like peptide-1 analog, liraglutide, delays the onset of diabetes and lowers triglycerides in UCD-T2DM rats. Diabetes (2010) 0.96
Crystal structure of a prolactin receptor antagonist bound to the extracellular domain of the prolactin receptor. J Biol Chem (2008) 0.94
Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model. Blood (2012) 0.94
Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice. Diabetes (2013) 0.93
Glucagon fibril polymorphism reflects differences in protofilament backbone structure. J Mol Biol (2010) 0.93
Identification and in vivo and in vitro characterization of long acting and melanocortin 4 receptor (MC4-R) selective α-melanocyte-stimulating hormone (α-MSH) analogues. J Med Chem (2012) 0.93
Design, synthesis, structural and functional characterization of novel melanocortin agonists based on the cyclotide kalata B1. J Biol Chem (2012) 0.91
The young Göttingen minipig as a model of childhood and adolescent obesity: influence of diet and gender. Obesity (Silver Spring) (2013) 0.89
The existence of multiple conformers of interleukin-21 directs engineering of a superpotent analogue. J Biol Chem (2007) 0.88
Gender-associated differences in metabolic syndrome-related parameters in Göttingen minipigs. Comp Med (2007) 0.88
Molecular determinants of high affinity binding to group III metabotropic glutamate receptors. J Biol Chem (2001) 0.87
Influence of castration-induced testosterone and estradiol deficiency on obesity and glucose metabolism in male Göttingen minipigs. Steroids (2010) 0.86
Ultrasound can predict regenerate stiffness in distraction osteogenesis. Clin Orthop Relat Res (2002) 0.86
Characterization of murine melanocortin receptors mediating adipocyte lipolysis and examination of signalling pathways involved. Mol Cell Endocrinol (2011) 0.86
Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations. J Clin Endocrinol Metab (2014) 0.86
Efficient generation, storage, and manipulation of fully flexible pharmacophore multiplets and their use in 3-D similarity searching. J Chem Inf Comput Sci (2003) 0.86
Evaluation of different methods for assessment of insulin sensitivity in Gottingen minipigs: introduction of a new, simpler method. Am J Physiol Regul Integr Comp Physiol (2009) 0.85
Pegylated long-acting human growth hormone possesses a promising once-weekly treatment profile, and multiple dosing is well tolerated in adult patients with growth hormone deficiency. J Clin Endocrinol Metab (2010) 0.85
Increase of neuronal histamine in obese rats is associated with decreases in body weight and plasma triglycerides. Obesity (Silver Spring) (2006) 0.83
1-alkyl-4-acylpiperazines as a new class of imidazole-free histamine H(3) receptor antagonists. J Med Chem (2004) 0.81
Investigation of safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of a long-acting α-MSH analog in healthy overweight and obese subjects. J Clin Pharmacol (2013) 0.81
Effects of a maternal diet supplemented with chocolate and fructose beverage during gestation and lactation on rat dams and their offspring. Clin Exp Pharmacol Physiol (2011) 0.80
Kinetics of degradation and oil solubility of ester prodrugs of a model dipeptide (Gly-Phe). Eur J Pharm Sci (2004) 0.80
Physiology of meiosis-activating sterol: endogenous formation and mode of action. Hum Reprod (2003) 0.79
Parallel solid-phase synthesis of disubstituted (5-biphenyltetrazolyl) hydantoins and thiohydantoins targeting the growth hormone secretagogue receptor. Bioorg Med Chem Lett (2004) 0.79
Evidence against glycogen cycling of gluconeogenic substrates in various liver preparations. J Biol Chem (2002) 0.79
Early onset inflammation in pre-insulin-resistant diet-induced obese rats does not affect the vasoreactivity of isolated small mesenteric arteries. Pharmacology (2012) 0.79
Fluctuating hyperglycaemia increases oxidative stress response in lean rats compared to sustained hyperglycaemia despite lower glycaemic exposure. Diab Vasc Dis Res (2011) 0.78
Discovery of the improved antagonistic prolactin variants by library screening. Protein Eng Des Sel (2011) 0.78
Novel α-MSH analog causes weight loss in obese rats and minipigs and improves insulin sensitivity. J Endocrinol (2014) 0.77
Laparoscopic Roux-en-Y gastric bypass in super obese Göttingen minipigs. Am J Transl Res (2013) 0.76
Does Glucagon-like Peptide-1 Ameliorate Oxidative Stress in Diabetes? Evidence Based on Experimental and Clinical Studies. Curr Diabetes Rev (2016) 0.75
Library of biphenyl privileged substructures using a safety-catch linker approach. J Comb Chem (2008) 0.75
Kinetics of degradation of 4-imidazolidinone prodrug types obtained from reacting prilocaine with formaldehyde and acetaldehyde. Eur J Pharm Sci (2003) 0.75
The influence of conformational restriction in the C-terminus of growth hormone secretagogues on their potency. Eur J Med Chem (2002) 0.75
Head-to-backbone cyclization of peptides on solid support by nucleophilic aromatic substitution. J Org Chem (2002) 0.75
Physicochemical characteristics and in vitro release from oil-based vehicles of peptidomimetics: parenteral depots for intra-articular administration. Drug Dev Ind Pharm (2010) 0.75
Diastereoselective synthesis of 2-aminoalkyl-3-sulfonyl-1,3-oxazolidines on solid support. J Org Chem (2002) 0.75